Bicon Pharma Lands $250 Million in PE Capital from PAG Asia

Bicon Pharma, a Xian maker of APIs and finished drugs, received a massive $250 million in fresh capital from private equity fund PAG Asia Capital. PAG spent last year amassing its $1.7 billion war chest and is now deploying funds. Bicon said the investment will be used to make acquisitions and to fund a large complex in Jiangsu province that includes space for R&D as well as manufacturing. More details.... Share this with colleagues: var switchTo5x=true; stLight.options({publisher:'d7871f5b-67bc-4d30-b66f-1465d0b97213'});